# Y-90 Versus SBRT for Inoperable HCC

> **NCT05157451** · PHASE2 · WITHDRAWN · sponsor: **OHSU Knight Cancer Institute**

## Conditions studied

- Hepatocellular Carcinoma
- Stage I Hepatocellular Carcinoma AJCC v8
- Stage IA Hepatocellular Carcinoma AJCC v8
- Stage IB Hepatocellular Carcinoma AJCC v8
- Stage II Hepatocellular Carcinoma AJCC v8
- Stage III Hepatocellular Carcinoma AJCC v8
- Stage IIIA Hepatocellular Carcinoma AJCC v8
- Stage IIIB Hepatocellular Carcinoma AJCC v8
- Stage IVA Hepatocellular Carcinoma AJCC v8

## Interventions

- **OTHER:** Quality of Life
- **OTHER:** Questionnaire Administration
- **RADIATION:** Stereotactic Body Radiation Therapy
- **PROCEDURE:** Yttrium-90 Microsphere Radioembolization

## Key facts

- **NCT ID:** NCT05157451
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-12-01
- **Primary completion:** 2026-01-05
- **Final completion:** 2026-01-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Not feasible at this time.
- **Last updated:** 2023-03-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05157451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05157451, "Y-90 Versus SBRT for Inoperable HCC". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT05157451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*